介酶干细胞衍生的外体细胞用于控制移植对宿主疾病:更新的观点
Zahra Shafeghat1, Maryam Dorfaki2, Shiva Dehrouyeh1
1Department of Immunology, School of medicine, Iran University of Medical Sciences, Tehran, Iran.
Transplant immunology
|November 7, 2023
概括
在干细胞移植后,介质干细胞衍生的外体在治疗移植对宿主疾病 (GvHD) 中表现有前途. 这种疗法减少了GvHD症状,并通过调节免疫反应改善了生存率.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 再生医学是一种再生医学.
背景情况:
- 移植与宿主疾病 (GvHD) 是血液造血干细胞移植 (HSCT) 的主要并发症,限制了其用于血液癌症的使用.
- GvHD涉及捐赠者T细胞攻击受体抗原和免疫失调,导致全身炎症.
- 目前的GvHD治疗方法,主要是皮质类固醇,缺乏完全的疗效.
研究的目的:
- 审查介质干细胞 (MSC) 及其衍生外体的治疗潜力,用于治疗GvHD.
- 探索MSC衍生的外基因组在GvHD中发挥免疫抑制作用的机制.
- 为GvHD提供MSC外体治疗的全面概述.
主要方法:
- 对MSCs,外体和GvHD治疗现有文献的审查.
- 对研究MSC衍生的外体对免疫细胞的影响和GvHD病理学的研究分析.
- 对外体特征,制备和绝育方法的检查.
主要成果:
- 从MSC衍生的外体体显示,GvHD临床症状显著降低,HSCT接受者的生存率改善.
- 外体细胞有效地抑制了激活自然杀手 (NK) 细胞释放的炎症性细胞因子,如IFN-γ和TNF-α.
- 这种抑制导致NK细胞细胞毒性功能和炎症反应减少,减轻GvHD的严重程度.
结论:
- 来自MSC的外体体是对GvHD的有前途的无细胞治疗策略.
- 外体疗法提供了一个潜在的更安全和更有效的替代方案或补充目前的GvHD治疗方法.
- 对MSC外体治疗的进一步研究可以促进癌症患者的HSCT结果.
相关概念视频
01:19Mesenchymal Stem Cells
4.8K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.8K
01:22Bone Marrow Sampling and Transplants
339
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
339
01:19Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
01:36Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
01:21Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
01:40Cell-mediated Immune Responses
68.6K
Overview
68.6K